BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30597292)

  • 1. Rosmarinic acid protects mice from lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting MAPKs/NF-κB and activating Nrf2/HO-1 signaling pathways.
    Li Z; Feng H; Wang Y; Shen B; Tian Y; Wu L; Zhang Q; Jin M; Liu G
    Int Immunopharmacol; 2019 Feb; 67():465-472. PubMed ID: 30597292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatoprotective effect of chiisanoside from Acanthopanax sessiliflorus against LPS/D-GalN-induced acute liver injury by inhibiting NF-κB and activating Nrf2/HO-1 signaling pathways.
    Bian X; Liu X; Liu J; Zhao Y; Li H; Zhang L; Li P; Gao Y
    J Sci Food Agric; 2019 May; 99(7):3283-3290. PubMed ID: 30552777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective Effects of Sesquiterpenoids from the Root of Panax ginseng on Fulminant Liver Injury Induced by Lipopolysaccharide/d-Galactosamine.
    Wang W; Zhang Y; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
    J Agric Food Chem; 2018 Jul; 66(29):7758-7763. PubMed ID: 29974747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Madecassoside prevents acute liver failure in LPS/D-GalN-induced mice by inhibiting p38/NF-κB and activating Nrf2/HO-1 signaling.
    Wang W; Wu L; Li Q; Zhang Z; Xu L; Lin C; Gao L; Zhao K; Liang F; Zhang Q; Zhou M; Jiang W
    Biomed Pharmacother; 2018 Jul; 103():1137-1145. PubMed ID: 29715757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Panaxynol from
    Sun X; Zhang T; Zhao Y; Cai E; Zhu H; Liu S
    Biotech Histochem; 2020 Nov; 95(8):575-583. PubMed ID: 32295432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of tenuigenin on lipopolysaccharide and d-galactosamine-induced acute liver injury.
    Jia R; Zhang H; Zhang W; Zhao H; Zha C; Liu Y
    Microb Pathog; 2017 Nov; 112():83-88. PubMed ID: 28958948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Andrographolide ameliorates d-galactosamine/lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway.
    Pan CW; Yang SX; Pan ZZ; Zheng B; Wang JZ; Lu GR; Xue ZX; Xu CL
    Oncotarget; 2017 Jun; 8(25):41202-41210. PubMed ID: 28465482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of morin on lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting TLR4/NF-κB and activating Nrf2/HO-1 signaling pathways.
    Tian Y; Li Z; Shen B; Zhang Q; Feng H
    Int Immunopharmacol; 2017 Apr; 45():148-155. PubMed ID: 28213269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of baicalin against lipopolysaccharide/D-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1.
    Wan JY; Gong X; Zhang L; Li HZ; Zhou YF; Zhou QX
    Eur J Pharmacol; 2008 Jun; 587(1-3):302-8. PubMed ID: 18420187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin attenuates lipopolysaccharide/d-galactosamine-induced acute liver injury by activating Nrf2 nuclear translocation and inhibiting NF-kB activation.
    Xie YL; Chu JG; Jian XM; Dong JZ; Wang LP; Li GX; Yang NB
    Biomed Pharmacother; 2017 Jul; 91():70-77. PubMed ID: 28448872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amygdalin attenuates acute liver injury induced by D-galactosamine and lipopolysaccharide by regulating the NLRP3, NF-κB and Nrf2/NQO1 signalling pathways.
    Tang F; Fan K; Wang K; Bian C
    Biomed Pharmacother; 2019 Mar; 111():527-536. PubMed ID: 30597306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maresin 1 protects against lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting macrophage pyroptosis and inflammatory response.
    Yang W; Tao K; Zhang P; Chen X; Sun X; Li R
    Biochem Pharmacol; 2022 Jan; 195():114863. PubMed ID: 34861244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxyresveratrol prevents lipopolysaccharide/d-galactosamine-induced acute liver injury in mice.
    Jia YN; Lu HP; Peng YL; Zhang BS; Gong XB; Su J; Zhou Y; Pan MH; Xu L
    Int Immunopharmacol; 2018 Mar; 56():105-112. PubMed ID: 29414639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of oroxylin A against lipopolysaccharide and/or D-galactosamine-induced acute liver injury in mice.
    Huang H; Zhang X; Li J
    J Surg Res; 2015 May; 195(2):522-8. PubMed ID: 25818981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isovitexin alleviates liver injury induced by lipopolysaccharide/d-galactosamine by activating Nrf2 and inhibiting NF-κB activation.
    Hu JJ; Wang H; Pan CW; Lin MX
    Microb Pathog; 2018 Jun; 119():86-92. PubMed ID: 29604422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of Xuebijing injection on D-galactosamine- and lipopolysaccharide-induced acute liver injury in rats through the regulation of p38 MAPK, MMP-9 and HO-1 expression by increasing TIPE2 expression.
    Liu MW; Liu R; Wu HY; Zhang W; Xia J; Dong MN; Yu W; Wang Q; Xie FM; Wang R; Huang YQ; Qian CY
    Int J Mol Med; 2016 Nov; 38(5):1419-1432. PubMed ID: 27666960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatoprotective effect of α-mangostin against lipopolysaccharide/d-galactosamine-induced acute liver failure in mice.
    Fu T; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
    Biomed Pharmacother; 2018 Oct; 106():896-901. PubMed ID: 30119260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of linalool against lipopolysaccharide/D-galactosamine-induced liver injury in mice.
    Li J; Zhang X; Huang H
    Int Immunopharmacol; 2014 Dec; 23(2):523-9. PubMed ID: 25311666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maslinic acid protects against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice.
    Wang YY; Diao BZ; Zhong LH; Lu BL; Cheng Y; Yu L; Zhu LY
    Microb Pathog; 2018 Jun; 119():49-53. PubMed ID: 29627448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sinapic acid ameliorates D-galactosamine/lipopolysaccharide-induced fulminant hepatitis in rats: Role of nuclear factor erythroid-related factor 2/heme oxygenase-1 pathways.
    Ansari MA; Raish M; Bin Jardan YA; Ahmad A; Shahid M; Ahmad SF; Haq N; Khan MR; Bakheet SA
    World J Gastroenterol; 2021 Feb; 27(7):592-608. PubMed ID: 33642831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.